Sign in
BIOR Stock Price, Chart, Stats & News
Biora Therapeutics, Inc.
Save
Biora Therapeutics, Inc. (BIOR) does not currently pay a dividend.
–
Market cap
0.61x
Current P/E
–
Forward P/E
BIOR chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 100.00% |
Operating margin | -1678575.00% |
Pretax margin | -3110600.00% |
Net margin | -3102875.00% |
Effective tax rate | 0.07% |
ROA | -397.61% |
ROE | 121.86% |
D/E | -0.47x |
Interest coverage ratio | -6.84x |
BIOR valuation
P/E | 0.61x |
P/S | 248.75x |
P/B | -0.00x |
P/CF | -0.01x |
P/FCF | -0.02x |
P/OCF | -0.01x |
PEG | 0.00x |
EV multiple | 0.27x |
About
Biora Therapeutics, Inc. is a biotechnology company focused on developing cutting-edge oral biotherapeutic solutions. The company's core efforts involve two main therapeutic programs: Targeted Therapeutics: This program utilizes an advanced ingestible smart capsule designed to deliver medications precisely within the gastrointestinal (GI) tract. The aim is to significantly improve therapies for inflammatory bowel diseases.
Similar securities
Based on sector and market capitalization
Report issue